Ovarian Plus: Gynecologic Cancer Prevention News

Volume 2 Number 4 ISSN 1083-4079 Winter 1997
Excerpts only

Contents

THE STRANGE BEGINNINGS OF OVARIAN CANCER ADVOCACY
By Ceil Sinnex
The ovarian-cancer advocacy movement went public six years ago this January, but the groundwork was laid in 1989. Here's how it all began, with a public servant's deceptive answer to my straightforward question about the National Cancer Institute's ovarian cancer research budget.

STATISTICS, ETHICS AND OVARIAN CANCER
By Steven Skates, PhD Assistant Professor of Medicine-Biostatistics Harvard Medical School
Behind the scenes with a major ovarian-cancer researcher, who explains the fascinating role of biostatisticians in determining whether research such as "clinical trials" is ethically sound. The inside track on how research is designed.

NEW OVARIAN CANCER DETECTION TEST: CREATIVE OPPORTUNITY OF A LIFETIME
By Steven Skates, PhD
The standard method for using CA125II blood tests assumes a positive (abnormal) result if the level exceeds 30 or 35 units/ml... However, by examining the CA125II levels over time, where the first result from each woman would determine her own baseline level, we believe we can substantially improve the performance of the screening program.

BOOK REVIEWS

* SURGERY ELECTIVES by John McCabe, Carmania Books, 1997. "For any woman or man anticipating surgery, it's a must-read."

* IN THE CONSTELLATION OF THE CRAB, By Doris Brett. Hale & Iremonger, (Australia) 1996. US $15 Visa or Mastercard, fax 61-2-550-2012. Award-winning poetry by an ovarian cancer survivor.

OUR SUBSCRIBERS: WHO YOU ARE

* You live in Australia, New Zealand, Japan, England, Belgium, Canada and the United States.

* And those from the U.S. hail from 37 states.

* You are homemakers, physicians, artists, students, lawyers, entrepreneurs, nurses, and more....and among you are major (National Institutes of Health-designated) comprehensive cancer centers.

* You want more, more, more about research, the CA125II test, endometrial and fallopian tube cancer as well as ovarian, diet, and family history concerns.

RESEARCH, RESEARCH, RESEARCH!

Your favorite feature. Packed with citations to the medical literature...and we encourage all laypersons and healthcare consumers to become accustomed to medical literature. Here's a painless way. This issue features many citations on psychological coping style.

OUR KIND OF PSYCHOLOGIST
By Ceil Sinnex
High monitors, whose coping style is to seek information, are often not treated appropriately in medical settings, according to Suzanne M. Miller, PhD. Dr. Miller provides tips for high monitors whose concern is ovarian cancer.

Copyright (C) 1997 by Ceil Sinnex

Published by OVARIAN PLUS (TM)

The only newsletter dedicated strictly to prevention of ovarian cancer and other gynecologic cancers + for all women and the people who love them

MISSION: To achieve and sustain a significant reduction in the number of women who die from ovarian cancer and other gynecologic cancers, through education and political awareness.

All rights reserved under international and Pan-American copyright conventions.

Information published in OVARIAN PLUS (TM) is not to be construed as medical or professional advice. Readers should always consult their physicians for advice and treatment. OVARIAN PLUS does not endorse any research results or treatments reported.

Bylined articles represent the views of the authors, not necessarily those of the publisher.

The title OVARIAN PLUS (TM) is a trademark belonging to Ceil Sinnex.

REPRINTS: Reproduction of OVARIAN PLUS without prior written permission is prohibited, except:
Bona fide subscribers may reprint up to 100 words without further permission, if they mail a copy to OVARIAN PLUS and credit the newsletter thus: "Reprinted from OVARIAN PLUS (TM): Gynecologic Cancer prevention Newsletter"; and make every attempt to add the name of the author of the piece.